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Genetic Engineering And Enhancement. Gene Therapy And Transhumanism  
To Debate 
Methodology 
In this review, the most recent publications, either reviews or conventional articles related to 
gene therapy and transhumanism were studied. Firstly, a search of the terms gene therapy, 
ethics, transhumanism was held in Pubmed, Sciencedirect and ARE, and the articles found 
were ordered by adaptation and impact. Secondly, the most important articles were read and 
summarized, analyzing the bibliography. Finally, high-impact journals were periodically 
examined in the search of new publications. This method was made to achieve the following 
objectives:  1. Describe the different  ethical opinions surrounding TG.  
  2. Treat different positions concerning GE as enhancer. 
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Should we use Gene Therapy? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) No sufficient data about side-effects 
(2) When treatment is applied, genome is changed 
permanently  patients could suffer more than 
expected. 
(3) Remove sequences that cause disorders  
decrease in variability (Anti-Nature) 
(4) In Germinal Gene Therapy (GGT), no informed 
consent would be signed by the developed 
individual 
(5) High costs  discrimination by economical 
reasons 
(6) The only way to improve knowledge is by 
investigating everything  we want 
(7) The most important potential benefit, overall 
by GGT 
(8) For parents prone to genetic diseases, could be 
the solution  reduction of abortions 
 
 
 
 
 
Should We Use Gene Therapy 
For Enchancement? 
 
Against In Favor 
1 
Transhumanism is a cultural and 
intellectual school of thought 
that pursues the human 
condition’s transformation by 
developing technologies which 
can improve humanity 
psychologically, physically and 
mentally.  
Figure 2. Transhumanism 
symbol. Obtained from 
http://goo.gl/O3ZyF0 
Against 
• Variability's end: everyone would want 
the best memory, intelligence, immortality 
 Creation of “ideal genome” (Fig. 3) 
• Injustice: high costs rich people who 
want to improve their skills will have the 
opportunity, while the poor cannot. It 
would lead to Discrimination similar to 
GATTACA (Fig. 1) 
• Change of embryos without knowing which 
would be his will 
• Scission of humanity in two being 
kinds: human and post-human 
In 
Favor 
• Efficiency: cultural and personal 
development could be refined 
• Freedom: to enhance ourselves as we do 
now physically (make-up, tattoos...) 
• Assisted reproductive technology  
eugenic  enhancement has to be allowed 
too.  
• Evolution: people immune to infectious 
diseases, senescence  suitable to the 
environment (Fig. 3) 
• Concept of normality: if therapeutics 
are morally allowed and there is no 
difference between treat and enhance, 
improvement has to be morally accepted 
(sorites paradox) 
Figure 1. GATTACA (Andrew Nicol, 
1997). “I belonged to a new 
underclass, no longer determined by 
social status or the color of your skin. 
No, we now have discrimination down 
to a science” (Vincent Freeman) . 
Obtained from http://goo.gl/NrKvgr 
Figure 3. Captain America, what 
somebody could become with 
enhancement techniques.  
Obtained from http://goo.gl/QUMnv4 
Introduction 
After the early advances in molecular biology, scientists started to investigate about new 
techniques that could revoke genetic alterations by editing the patients’ genome, also called 
Genetic Engineering (GE). Thus, the first method applied to humans was called Gene 
Therapy (GT), in 1990. However, in September 1999, a boy died because of the secondary 
effects of gene therapy. Then, governments started be more strict regulating clinical trials. 
Given the potential of GE, healthy people could voluntarily change their own genetic code to 
improve some biological skills. The school of thought that supports this kind of GE 
applications is Transhumanism (H+)  
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Population concerns 
A survey was made in USA and Canada about Gene 
Therapy uses. They obtained 470 valid responses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All of them were asked if GT use would be acceptable 
in different situations: Alzheimer disease, attention 
deficit hyperactivity disorder (ADHD) and normal 
memory enhancement (Fig. 4). Then they answered 
about acceptable enhancement forms(Fig. 5). 
 
 
 
 
 
 
 
 
 
 
 
The majority of participants accepted GT, being the 
acceptability greater as diseases are more severe. Most 
participants accepted GT for enhancement purposes. 
 
 
In 2015 a Chinese research group created the first 
transgenic human zygotes (Fig. 6) with a technique 
called CRISPR/Cas9 to cure β-thalassemia (2). 
Due overall to the off-target mutations the technique 
provokes, results obtained show that GT is not safe 
     enough to treat human 
     species and further 
     investigation is needed 
     before application. 
Figure 4. Acceptability of gene therapy for different applications, 
depending on three different conditions (1) 
tion concerns 
Figure 5. Acceptability of different enhancement forms. Percentage 
of acceptance of participants for five different forms (1) 
China creates first genetically 
modified human embryos 
1. Further investigation is needed to ensure Gene Therapy is safe for the population before it is clinically applied.  
2. More ethical debate has to be opened to agree about if Gene Therapy treatments should be used or not and to what purpose, since Genetic Engineering potential is 
widely greater than only cure. 
3. Information about Genetic Engineering should be given to population, not only about the medical consequences but also about the social ones.  
4. For American population it would be acceptable to use Gene Therapy to treat and to enhance people. More surveys have to be done in other countries.  
 
 
 
  
 
 
 
Conclusions 
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Figure 6. Tripronuclear zygote. It has 
3 genome copies (discarded from 
clinical trials). Its edition has raised  
